Get the Stockscreener App
4.22
9.05%
-0.42
Evolent Health Inc stock is traded at $4.22, with a volume of 5.64M.
It is down -9.05% in the last 24 hours and down -16.10% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
See More
Previous Close:
$4.64
Open:
$4.64
24h Volume:
5.64M
Relative Volume:
2.08
Market Cap:
$474.67M
Revenue:
$1.89B
Net Income/Loss:
$-496.52M
P/E Ratio:
-0.8866
EPS:
-4.7598
Net Cash Flow:
$1.40M
1W Performance:
-27.37%
1M Performance:
-16.10%
6M Performance:
+7.11%
1Y Performance:
-54.87%
1-Day Range:
$4.075
$4.70
1-Week Range:
$4.075
$6.00
52-Week Range:
$2.095
$10.29
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, HQY, TEM, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
4.22 | 474.67M | 1.89B | -496.52M | 1.40M | -4.7598 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-13-25 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health, Inc Revenue Breakdown – NYSE:EVH - TradingView
EVH|Evolent Health Inc|Price:4.220|Chg%:-0.425 - TradingKey
Evolent Health (EVH) Downgraded to Neutral by Citi with Revised Price Target - GuruFocus
Evolent Health, Inc Stock 12‑Month Price Target Raised to $6.06, Implies 9% Upside - TradingView
TRHC stock reflects ongoing integration as Tabula Rasa HealthCare focuses on profitability after Evo - AD HOC NEWS
Why Evolent Health (EVH) Stock Is Nosediving - Yahoo Finance
EVH Downgraded by Citigroup -- Price Target Raised to $6.75 - GuruFocus
EVOLENT HEALTH INC : CITIGROUP CUTS TO NEUTRAL FROM BUY; RAISES TARGET PRICE TO $6.75 FROM $5.5 - Bitget
Evolent Health (EVH) Proxy filing Summary - Quartr
Evolent Health stock trades steady as revenue grows and margins expand - AD HOC NEWS
Evolent Health Inc Class A (EVH) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Avoiding Lag: Real-Time Signals in (EVH) Movement - Stock Traders Daily
ETFs Investing in Evolent Health Inc Class A Stocks - TradingView
BlackRock Portfolio Management (NYSE: EVH) discloses 5.5% Evolent Health ownership - Stock Titan
Evolent Health: The De-Risking Is Working, But Leverage Keeps Me On Hold (NYSE:EVH) - Seeking Alpha
Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now - Yahoo Finance
Evolent To Release Second Quarter 2026 Financial Results on Thur - GuruFocus
EVH5958944 Bond Profile — Key Metrics - TradingView
EVH5958944 Bond Risk Profile - TradingView
EVH5958944 Bond Coupon Profile — Rate & Payments - TradingView
Evolent Health (EVH) Stephens 26th Annual Investment Conference | NASH2024 Summary - Quartr
Evolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026 - StreetInsider
How Highmark Blue Shield is collaborating on value-based cancer care - The Business Journals
How Highmark Blue Cross Blue Shield is collaborating on value-based cancer care - The Business Journals
EVHEvolent Health Inc Dividends - Finviz
Evolent Health (EVH) CEO gets 446,102 RSUs and has shares withheld for taxes - Stock Titan
Evolent Health | 4: Statement of changes in beneficial ownership of securities-Officer Weinberg Jonathan - Moomoo
Evolent Health (EVH) General Counsel receives RSU grant with tax-withholding entry - Stock Titan
Evolent Health (EVH) president receives 302,585 RSUs in equity grant - Stock Titan
Evolent Health (EVH) grants 28,790 RSUs to Chief Accounting Officer - Stock Titan
Evolent Health focuses on value-based care as investors watch long-term growth - Ad-hoc-news.de
Evolent Health Q1 2026 slides: revenue misses forecast, leverage rises - Investing.com
Should you buy Evolent Health (EVH) after golden cross? - MSN
Should You Buy Evolent Health (EVH) After Golden Cross? - Yahoo! Finance Canada
Truist Financial Downgrades Evolent Health(EVH.US) to Hold Rating, Maintains Target Price $7 - Moomoo
Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Maintains Target Price $7 - Moomoo
Truist cuts Evolent Health stock rating on Medicaid headwinds By Investing.com - Investing.com South Africa
Truist cuts Evolent Health stock rating on Medicaid headwinds - Investing.com
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength? - Yahoo Finance
Enterprise value to EBIT forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to sales forward of Evolent Health, Inc – NYSE:EVH - TradingView
Enterprise value to revenue forward of Evolent Health, Inc – NYSE:EVH - TradingView
Price to sales forward of Evolent Health Inc Class A – FWB:9EH - TradingView
Price to earnings forward of Evolent Health, Inc – NYSE:EVH - TradingView
Evolent Health Inc (EVH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Evolent Health quarterly loss narrows, shares react to value-based care focus - AD HOC NEWS
Discipline and Rules-Based Execution in EVH Response - Stock Traders Daily
Evolent Health Inc Class A Actuals & Estimates (NYSE:EVH) - TradingView
EVH Forecast — Price Target — Prediction for 2027 - TradingView
Citigroup Maintains Evolent Health (EVH) Buy Recommendation - MSN
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.99%
2.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):